Bryan Barber
Direttore/Membro del Consiglio presso Myonexus Therapeutics, Inc.
Profilo
Bryan Barber is the founder of ADVANTIS Global, Inc. which was founded in 2007, where he held the title of President.
Currently, he is the Director & VP-Pharmaceutical Development at Myonexus Therapeutics, Inc.
Posizioni attive di Bryan Barber
| Società | Posizione | Inizio |
|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Bryan Barber
| Società | Posizione | Fine |
|---|---|---|
ADVANTIS Global, Inc.
 ADVANTIS Global, Inc. Information Technology ServicesTechnology Services ADVANTIS Global, Inc. engages in the provision of IT staffing solutions. It services include large-scale technical projects, temporary, and permanent staffing. The company was founded by Jeff Taylor and Bryan Barber in 2007 and is headquartered in Mill Valley, CA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
ADVANTIS Global, Inc.
ADVANTIS Global, Inc. Information Technology ServicesTechnology Services ADVANTIS Global, Inc. engages in the provision of IT staffing solutions. It services include large-scale technical projects, temporary, and permanent staffing. The company was founded by Jeff Taylor and Bryan Barber in 2007 and is headquartered in Mill Valley, CA. | Technology Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
- Borsa valori
- Insiders
- Bryan Barber
